重症监护病房中β-内酰胺类及其他抗生素的治疗药物监测:哪些药物、哪些患者、哪些感染?
该综述针对成人重症监护病房中抗菌药物的治疗药物监测(TDM)进行阐述,指出重症患者药代动力学变异大,TDM是评估抗生素暴露是否充分的最实用手段。文章回顾了糖肽类、氨基糖苷类、喹诺酮类和β-内酰胺类TDM的基本要求、适应证和目标,重点聚焦于最广泛使用的β-内酰胺类抗生素。
要点
- 重症患者抗菌药物药代动力学个体间和个体内变异大,TDM是评估暴露充分性的实用手段。
- β-内酰胺类历史上被认为治疗窗宽,但TDM正日益广泛应用于该类药物的剂量优化。
- 综述涵盖糖肽类、氨基糖苷类、喹诺酮类和β-内酰胺类在成人ICU中的TDM要求与目标。
核心结论
- TDM是评估重症患者抗生素暴露是否充分的最实用手段,但长期以来未充分利用,目前尤其在β-内酰胺类中正逐步推广。
研究设计与样本
- 综述,聚焦成人重症监护病房中糖肽类、氨基糖苷类、喹诺酮类和β-内酰胺类抗生素的TDM基本要求、适应证和目标。
主要发现
- 重症患者抗菌药物存在高度的个体内和个体间药代动力学变异。
- 近几十年来对重症患者抗生素剂量、暴露与临床效应之间关系的认识有所增加。
- β-内酰胺类是最广泛使用的抗生素类别,历史上被认为治疗窗宽,但TDM正日益应用于该类药物的暴露评估。
临床怎么用
- 对重症监护病房患者,尤其使用β-内酰胺类抗生素时,应考虑通过TDM评估抗生素暴露是否充分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antibiotics are among the medications most frequently administered to the critically ill, a population with high levels of intra- and inter-individual pharmacokinetic variability. Our knowledge of the relationships among antibiotic dosing, exposure and clinical effect in this population has increased in recent decades. Therapeutic drug monitoring (TDM) of serum antibiotic concentrations is the most practical means of assessing adequate antibiotic exposure, though until recently, it has been underutilised for this end. Now TDM is becoming more widespread, particularly for the beta-lactam antibiotics, a class historically thought to have a wide therapeutic range. We review the basic requirements, indications, and targets for effective TDM of the glycopeptides, aminoglycosides, quinolones and beta-lactam antibiotics in the adult intensive-care setting, with a special focus on TDM of the beta-lactam antibiotics, the most widely used antibiotic class.
引用
- Muller AE, Huttner B, Huttner A, et al. Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections? Drugs. 2018. PMID: 29476349. doi:10.1007/s40265-018-0880-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。